Prevalence and predictors of ventricular remodeling after anterior myocardial infarction in the era of modern medical therapy

Medical Science Monitor

Volumn 18, Issue 5, 2012, Pages

  Farah, Elaine ^a   Cogni, Ana Lucia ^a   Minicucci, Marcos F ^a   Azevedo, Paula S ^a   Okoshi, Katashi ^a   Matsubara, Beatriz B ^a   Zanati, Silméia G ^a   Haggeman, Rodrigo ^a   Paiva, Sergio A R ^a   Zornoff, Leonardo A M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Predictors; Remodeling; Ventricular dilation

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SPIRONOLACTONE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIASTOLE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; REPERFUSION; TREATMENT DURATION;

EID: 84860682018     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882732     Document Type: Article

References (28)

1. Duarte DR, Minicucci MF, Azevedo PS et al: Influence of lisinopril on cardiac remodeling induced by tobacco smoke exposure. Med Sci Monit, 2010; 16(8): BR255-BR259
2. Oliveira Junior SA, Dal Pai-Silva M, Martinez PF et al: Diet-induced obesity causes metabolic, endocrine and cardiac alterations in spontaneously hypertensive rats. Med Sci Monit, 2010; 16(12): BR367-BR373.
3. Oliveira Junior SA, Dal Pai-Silva M, Martinez PF et al: Differential nutritional, endocrine, and cardiovascular effects in obesity-prone and obesity- resistant rats fed standard and hypercaloric diets. Med Sci Monit, 2010; 16(7): BR208-BR217
4. Cohn JN, Ferrari R, Sharpe N: Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol, 2000; 35: 569-82
5. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation, 1990; 81: 1161-72
6. Gaudron P, Eilles C, Kugler I, Ertl G: Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation, 1993; 87: 755-63
7. Zornoff LAM, Paiva SAR, Duarte DR, Sparado J: Ventricular remodeling after myocardial infarction: concepts and clinical implications. Arq Bras Cardiol, 2009; 92: 157-64
8. Bolognese L, Cerisano G: Early predictors of left ventricular remodeling after acute myocardial infarction. Am Heart J, 1999; 138: S79-83
9. Savoye C, Equine O, Tricot O et al: Left ventricular after anterior wall acute myocardial infarction in modern clinical practice. Am J Cardiol, 2006; 98: 1144-49
10. Kushner FG, Hand M, Smith SC Jr et al: American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/ SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2009; 120: 2271-306
11. Pfeffer MA, McMurray JJ, Velazquez EJ et al: Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med, 2003; 349: 1893-906
12. Lang RM, Bierig M, Devereaux RB et al: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr, 2005; 18: 1440-1463
13. Merlo M, Pyxaras SA, Pinamonti B et al: Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol, 2011; 57: 1468-1476
14. Eaton LW, Bulkley BH: Expansion of acute myocardial infarction: its relationship to infarct morphology in a canine model. Circ Res, 1981; 49: 80-88
15. Hochman LS, Bulkley BH: Expansion of acute myocardial infarction: an experimental study. Circulation, 1982; 65: 1446-1450
16. Schuster EH, Bulkley BH: Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture. Circulation, 1979; 60: 1532-1538
17. Pirolo JS, Hutchins GM, Moore GW: Infarct expansion. Pathologic analysis of 204 patients with a single myocardial infarct. J Am Coll Cardiol, 1986; 7: 349-354
18. Jeremy RW, Hackworthy RA, Bautovich G et al: Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol, 1987; 9: 989-995
19. Jeremy RW, Allman KC, Bautovitch G, Harris PJ: Patterns of left ventricular dilation during the six months after myocardial infarction. J Am Coll Cardiol, 1989; 13: 304-310
20. Solomon SD, Pfeffer MA: The decreasing incidence of left ventricular remodeling following myocardial infarction. Basic Res Cardiol, 1997; 92: 61-65
21. Pfeffer MA, Lamas GA, Vaughan DE et al: Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med, 1988; 319: 80-86
22. Senior R, Basu S, Kinsey C et al: Carvedilol prevents remodeling in patients with left ventricular dysfunction after after acute myocardial infarction. Am Heart J, 1999; 137: 646-652
23. Bellenger NG, Swinburn JMA, Rajappan K et al: Cardiac remodeling in the era of aggressive medical therapy: does it still exist? Int J Cardiol, 2002; 83: 217-225
24. Loboz-Grudzien K, Kowalska A, Brzezinska B et al: Early predictors of adverse left ventricular remodelling after myocardial infarction treated by primary angioplasty. Cardiol J, 2007; 14: 238-425
25. Garcia-Alvarez A, Sitges M, Delgado V et al: Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. Am J Cardiol, 2009; 104: 878-882
26. Carrabba N, Parodi G, Valenti R et al: Comparison of effects of primary coronary angioplasty on left ventricular remodeling and heart failure in patients <70 versus > or =70 years with acute myocardial infarction. Am J Cardiol, 2009; 104: 926-931
27. Meta-Analysis Research Group in Echocardiography (MeRGE) AMI Collaborators. Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis: Meta-Analysis Research Group in Echocardiography acute myocardial infarction. Circulation, 2008; 117: 2591-2598
28. Pfeffer MA, Greaves SC, Arnold JMO et al: Early versus delayed angiotensin converting enzyme inhibition therapy in acute myocardial infarction: In the Healing and Early Afterload Reducing Therapy Trial. Circulation, 1997; 95: 2643-2651